Search results
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 6 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ...
FDA Expands Use of RSV Vaccine to Include More Adults
MedPage Today· 4 days agoThe FDA expanded the approval of GSK's respiratory syncytial virus (RSV) vaccine (Arexvy) to include...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 7 days agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial ...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via AOL· 6 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial ...
New RSV shots tied to rare nervous system disorder — should you worry?
LiveScience· 14 hours agoThe new RSV vaccines approved for older adults may be linked to a slightly increased risk of a rare...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 4 days agoOn the stock market today, Moderna stock fell 1.6% to close at 148.59. Shares have yo-yoed this...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 4 days agoGSK GSK announced that the FDA has approved the expanded use of its respiratory syncytial virus (RSV...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 2 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
Moderna’s next-gen COVID vaccine shows non-inferiority to its current shot
WSAU Wausau· 24 hours ago(Reuters) -Moderna said on Thursday its next-generation COVID-19vaccine candidate met its main goal...